Sionna scraps genetic disorder drug program after trial setback; shares tank

Sionna Therapeutics said on Monday it would stop developing its experimental drug as an addition to ​standard treatment for a type of genetic ‌disorder after it failed to show a meaningful benefit in ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。